AAAAAA

   
Results: 1-9 |
Results: 9
QUANTITATION OF HYALURONIDASES BY THE MORGAN-ELSON REACTION - COMPARISON OF THE ENZYME-ACTIVITIES IN THE PLASMA OF TUMOR PATIENTS AND HEALTHY-VOLUNTEERS
Authors: MUCKENSCHNABEL I BERNHARDT C SPRUSS T DIETL B BUSCHAUER A
Citation: I. Muckenschnabel et al., QUANTITATION OF HYALURONIDASES BY THE MORGAN-ELSON REACTION - COMPARISON OF THE ENZYME-ACTIVITIES IN THE PLASMA OF TUMOR PATIENTS AND HEALTHY-VOLUNTEERS, Cancer letters, 131(1), 1998, pp. 13-20
PHARMACOKINETICS AND TISSUE DISTRIBUTION OF BOVINE TESTICULAR HYALURONIDASE AND VINBLASTINE IN MICE - AN ATTEMPT TO OPTIMIZE THE MODE OF ADJUVANT HYALURONIDASE ADMINISTRATION IN CANCER-CHEMOTHERAPY
Authors: MUCKENSCHNABEL I BERNHARDT G SPRUSS T BUSCHAUER A
Citation: I. Muckenschnabel et al., PHARMACOKINETICS AND TISSUE DISTRIBUTION OF BOVINE TESTICULAR HYALURONIDASE AND VINBLASTINE IN MICE - AN ATTEMPT TO OPTIMIZE THE MODE OF ADJUVANT HYALURONIDASE ADMINISTRATION IN CANCER-CHEMOTHERAPY, Cancer letters, 131(1), 1998, pp. 71-84
PRECLINICAL TUMORPHARMACOLOGICAL AND PHARMACOKINETIC STUDIES ON THE ADJUVANT ADMINISTRATION OF HYALURONIDASE IN THE CHEMOTHERAPY OF MALIGNANT-MELANOMA
Authors: BERNHARDT G MUCKENSCHNABEL I SPRUSS T BUSCHAUER A
Citation: G. Bernhardt et al., PRECLINICAL TUMORPHARMACOLOGICAL AND PHARMACOKINETIC STUDIES ON THE ADJUVANT ADMINISTRATION OF HYALURONIDASE IN THE CHEMOTHERAPY OF MALIGNANT-MELANOMA, Naunyn-Schmiedeberg's archives of pharmacology, 358(1), 1998, pp. 458-458
A VERSATILE HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY METHOD FOR THE MEASUREMENT OF MELPHALAN TAILORED TO THE OPTIMIZATION OF HYPERTHERMIC ISOLATED LIMB PERFUSION
Authors: MUCKENSCHNABEL I BERNHARDT G SPRUSS T BUSCHAUER A
Citation: I. Muckenschnabel et al., A VERSATILE HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY METHOD FOR THE MEASUREMENT OF MELPHALAN TAILORED TO THE OPTIMIZATION OF HYPERTHERMIC ISOLATED LIMB PERFUSION, European journal of pharmaceutical sciences, 5(3), 1997, pp. 129-137
THE ADENOVIRUS E4ORF6 PROTEIN CAN PROMOTE E1A E1B-INDUCED FOCUS FORMATION BY INTERFERING WITH P53 TUMOR-SUPPRESSOR FUNCTION/
Authors: NEVELS M RUBENWOLF S SPRUSS T WOLF H DOBNER T
Citation: M. Nevels et al., THE ADENOVIRUS E4ORF6 PROTEIN CAN PROMOTE E1A E1B-INDUCED FOCUS FORMATION BY INTERFERING WITH P53 TUMOR-SUPPRESSOR FUNCTION/, Proceedings of the National Academy of Sciences of the United Statesof America, 94(4), 1997, pp. 1206-1211
HYALURONIDASE PRETREATMENT PRODUCES SELECTIVE MELPHALAN ENRICHMENT INMALIGNANT-MELANOMA IMPLANTED IN NUDE-MICE
Authors: MUCKENSCHNABEL I BERNHARDT G SPRUSS T BUSCHAUER A
Citation: I. Muckenschnabel et al., HYALURONIDASE PRETREATMENT PRODUCES SELECTIVE MELPHALAN ENRICHMENT INMALIGNANT-MELANOMA IMPLANTED IN NUDE-MICE, Cancer chemotherapy and pharmacology, 38(1), 1996, pp. 88-94
DEVELOPMENT OF A PARENTERALLY ADMINISTRABLE HYDROSOL PREPARATION OF THE 3RD-GENERATION PLATINUM COMPLEX [(+ -FLUOROPHENYL)ETHYLENEDIAMINE]DICHLOROPLATINUM(II) .1. PREPARATION AND STUDIES ON THE STABILITY AND ANTITUMOR-ACTIVITY/
Authors: GUST R BERNHARDT G SPRUSS T KRAUSER R KOCH M SCHOENENBERGER H BAUER KH SCHERTL S LU Z
Citation: R. Gust et al., DEVELOPMENT OF A PARENTERALLY ADMINISTRABLE HYDROSOL PREPARATION OF THE 3RD-GENERATION PLATINUM COMPLEX [(+ -FLUOROPHENYL)ETHYLENEDIAMINE]DICHLOROPLATINUM(II) .1. PREPARATION AND STUDIES ON THE STABILITY AND ANTITUMOR-ACTIVITY/, Archiv der pharmazie, 328(9), 1995, pp. 645-653
HYALURONIDASE SIGNIFICANTLY ENHANCES THE EFFICACY OF REGIONAL VINBLASTINE CHEMOTHERAPY OF MALIGNANT-MELANOMA
Authors: SPRUSS T BERNHARDT G SCHONENBERGER H SCHIESS W
Citation: T. Spruss et al., HYALURONIDASE SIGNIFICANTLY ENHANCES THE EFFICACY OF REGIONAL VINBLASTINE CHEMOTHERAPY OF MALIGNANT-MELANOMA, Journal of cancer research and clinical oncology, 121(4), 1995, pp. 193-202
DROXYPHENYL)ETHYLENEDIAMINE]-DICHLOROPLATINUM(II), A NEW DRUG NOT ONLY PARENTERALLY BUT ALSO ORALLY-ACTIVE IN THE THERAPY OF BREAST AND PROSTATE-CANCER
Authors: SPRUSS T SCHERTL S SCHNEIDER MR GUST R BAUER K SCHONENBERGER H
Citation: T. Spruss et al., DROXYPHENYL)ETHYLENEDIAMINE]-DICHLOROPLATINUM(II), A NEW DRUG NOT ONLY PARENTERALLY BUT ALSO ORALLY-ACTIVE IN THE THERAPY OF BREAST AND PROSTATE-CANCER, Journal of cancer research and clinical oncology, 119(12), 1993, pp. 707-716
Risultati: 1-9 |